Ageing demographics, rapid technological developments, increasing adoption of home infusion therapies, favourable government policies and regulations are are key factors contributing to high CAGR of Home infusion therapy during forecast period.
Market Size – USD 22.03 Billion in 2018, Market Growth – CAGR of 7.2%, Market Trends – Product launches and research for advanced Home infusion therapy
According to current analysis of Reports and Data, the global Home Infusion Therapy Market was valued at USD 22.03 billion in 2018 and is expected to reach USD 38.41 billion by the year 2026, at a CAGR of 7.2%. Infusion therapy involves the administration of drugs intravenously. It is prescribed when a patient’s condition is much severe and cannot be treated effectively by oral medications. Receiving this therapy in homecare settings rather than hospitals is referred to as home infusion therapy. Home infusion therapies are very cost-effective, and technological advancements have facilitated safe and effective administration of infusion therapies at home. The advantage infusion offers is that it helps deliver a precise dose of the drug quickly and efficiently, and in a well-controlled manner throughout the body. It is also used for irritating solutions; those can cause pain and even damage tissues if administered by subcutaneous or intramuscular injection.
To get your copy of the Home Infusion Therapy market report @ https://www.reportsanddata.com/sample-enquiry-form/2250
Moving care into the home is a very important step of change in healthcare. The approach is patient-centric. Home infusion therapy let patients reduce or even totally avoid outpatient hospital visits, and allows them to resume normal routines and work behaviors while still treating their illness. Home infusion therapy works closely with the patient to ensure that such services are appropriate and in the interest of the best patient care. Moreover, the outcome of home infusion therapy is reliable. Favorable government policies and regulations, increasing geriatric population, rapid technological developments, and increasing adoption of home infusion therapies, are some of the key factors propelling market growth in the industry. High prevalence of chronic diseases such as HIV, cancer, diabetes is further expected to fuel market growth. Home infusion drugs are often not readily available through standard pharmacies and comparatively higher in cost. Most are obtained through hospital pharmacies, licensed home infusion agencies, or mail-order discount drug supply companies that can express deliver the drugs directly to the patient’s home. However, increasing risk with patient’s safety and occurrence of mistakes while using infusion devices and issues related to reimbursement policies for home infusion therapy are the major hindrance for market growth during the forecast period.
Further key findings from the report suggest
- Home Infusion Therapy is growing at a CAGR of 3% in Asia Pacific followed by North America and Europe, with 7.2 % and 6.9% CAGR, respectively. High incidence of chronic diseases and availability of cost-effective home infusion therapies in developing and developed economies are expected to accelerate the market growth for home infusion therapy during forecast period across all regions
- As of 2018, Anti-infective application segment is expected to dominate Home infusion therapy which holds the market share of 33.9% of the global market. North America region is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions
- Chemotherapy is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 7.7%. It is also the second largest segment in terms of revenue generation after anti-infective segment. For instance, according to the data of cancer organization, by January 1 2030, it is estimated that the population of cancer survivors will increase to more than 22.1 million due to the growth and aging of the population alone
- Infusion pumps segment led the global infusion therapy market with a market share of 34.7% in 2018 and is forecasted to continue its dominance during the forecast period. Extensive application in delivering fluids containing nutrients and medications in controlled dosages is anticipated to fuel market growth
- Needleless connectors segment is anticipated to witness lucrative growth with a CAGR of 7.9% registering fastest growth during the forecast period.
- Key players in the home infusion therapy industry are taking initiatives to educate and promote home infusion therapy among the patients by providing educational tools and apps that can be utilized for infusion therapies. For instance, in October 2018, Baxter International Inc. in collaboration with American Society for Parenteral and Enteral Nutrition (ASPEN) launched SmartPN tool to help reduce clinical malnutrition.
- Asia Pacific is expected to account for the 21.1% of the global Home Infusion Therapy. Developing nations such China, and India are likely to witness high growth
- North America region accounts for the largest market share of 37.6% followed by Europe
- Key participants include Baxter, B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Terumo Corporation, JMS Co. Ltd., CareFusion Corporation, Smiths Medical and Caesarea Medical Electronics.
Read the Complete Report Overview @ https://www.reportsanddata.com/report-detail/home-infusion-therapy-market
For the purpose of this report, Reports and Data has segmented the Home Infusion Therapy on the basis of product, application, and region:
Product (Revenue, USD Million; 2016–2026)
- Infusion pumps
- Intravenous sets
- IV Cannulas
- Needleless connectors
Application (Revenue, USD Million; 2016–2026)
- Anti- infective
- Endocrinology
- Hydration therapy
- Chemotherapy
- Enteral nutrition
- Parenteral nutrition
- Special pharmaceuticals
Regional Outlook (Revenue in USD Million; 2016–2026)
- North America
- US.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
TOC of the Home Infusion Therapy Market Report:
Home Infusion Therapy Study Coverage
Executive Summary
Market Size by Application
Manufacturers Profiles
Production Forecasts
Consumption Forecast
Market Size by Manufacturers
Production by Regions
Consumption by Regions
Market Size by Type
Value Chain and Sales Channels Analysis
Home Infusion Therapy Market Opportunities & Challenges, Risks and Influences Factors Analysis.
Connect with an expert for customization of Report @ https://www.reportsanddata.com/request-customization-form/2250
Table of Contents
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Chapter 3. Indicative Metrics
3.1. Ageing demographics
3.2. Increasing incidences of chronic diseases
3.3. Rapid technological advancements
Chapter 4. Home Infusion Therapy Segmentation & Impact Analysis
4.1. Home Infusion Therapy Segmentation Analysis
4.2. Home Infusion Therapy Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Home Infusion Therapy Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. High prevalence of chronic disease across the world
4.4.1.2. Favourable government policies and regulations
4.4.2. Market restraint analysis
4.4.2.1. Increasing risk with patient’s safety while using infusion devices
4.4.2.2. Reimbursement policy issues
4.5. Key opportunities prioritized
4.6. Home Infusion Therapy Pricing Analysis
4.7. Industry analysis – Porter’s
4.8. Home Infusion Therapy PESTEL Analysis
Chapter 5. Home Infusion Therapy Market By Product Type Insights & Trends
Continued…
Thank you for reading the article. You can also get individual chapter-wise or region-wise section in the report.
